phase readout
saveNCT05203445: A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
ACTIVE_NOT_RECRUITINGupdated 2d ago
community read0 votes
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that